Pharmaceutical News

RSS

Pharmaceutical Benefits Scheme (PBS) medicines available faster

The time taken for medicines to list on the Pharmaceutical Benefits Scheme (PBS) will be significantly reduced under recommendations outlined in the report Working together to improve the Pharmaceutical Benefits Scheme - Review of the Post PBAC Processes Report released today.

27 Jul 2004

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Merck/Schering-Plough Pharmaceuticals has announced that the U.S. Food and Drug Administration has approved VYTORIN™ (ezetimibe/simvastatin) for the treatment of high LDL cholesterol (LDL-C) in patients with primary hypercholesterolemia or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough.

26 Jul 2004

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Y's Therapeutics, a privately held biopharmaceutical company, said today it has submitted applications to the Ethics Committee and Ministry of Health (BfArM) in Germany to begin Phase II clinical trials for its two most advanced projects, YSIL6 for rheumatoid arthritis and YSTH2 for asthma.

26 Jul 2004

Janssen Pharmaceutica has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®

Janssen Pharmaceutica, the maker of RISPERDAL® (risperidone), the most frequently prescribed antipsychotic medication in the U.S., has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®.

26 Jul 2004

The Internet has become the street corner for many drug users and traffickers

Operation Web Tryp investigated Internet websites distributing highly dangerous designer drug analogues under the guise of “research chemicals” primarily shipped to the U.S. from China and India. These websites are known to have thousands of customers worldwide.

26 Jul 2004

GlaxoSmithKline to stand trial on AIDS drugs

The Competition Tribunal of South Africa agreed late last week to hear the complaint filed by individual South Africans and AIDS Healthcare Foundation, a nongovernmental organization that operates a free AIDS treatment clinic in Durban, that British drug maker GlaxoSmithKline illegally excessively priced AIDS drugs in violation of the South African Competition Act.

26 Jul 2004

Plan B has been shown to reduce the risk of pregnancy by 89 percent

Barr Pharmaceuticals has announced that its subsidiary, Duramed Pharmaceuticals has submitted a formal response in support of its Supplemental New Drug Application (sNDA) for an Over-the-Counter (OTC) Plan B(R) emergency contraceptive product.

23 Jul 2004

New cream treatment for common form of skin cancer

The US Food and Drug Administration has approved a new treatment for some people with a very common form of skin cancer. Imiquimod cream, sold as Aldara, can now be used to treat superficial basal cell carcinoma.

23 Jul 2004

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Elan Corporation and Wyeth Pharmaceuticals have announced several key findings from their Phase IIa clinical trial of an investigational Alzheimer's disease (AD) treatment, AN-1792, which were presented in Philadelphia at the 9th International Conference on Alzheimer's Disease and Related Disorders.

22 Jul 2004

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab), offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an article written by two Mayo Clinic cancer researchers published in the current edition of the New England Journal of Medicine.

21 Jul 2004

Lower drug prices could eliminate coverage gap in Medicare Prescription Drug Plan

Medicare could eliminate the coverage gap in its prescription drug benefit if it paid pharmaceutical prices comparable to those paid by citizens of Canada, the United Kingdom and France, according to a report by researchers from the Johns Hopkins Bloomberg School of Public Health and Pennsylvania State University

21 Jul 2004

Court ruling favors State over pharmaceutical manufacturers

Nevada Attorney General Brian Sandoval yesterday announced that Washoe County District Court Judge Steven R. Kosach has issued an important ruling in Nevada's Average Wholesale Price (AWP) litigation against numerous pharmaceutical manufacturers including Abbott Labs, Baxter, Bristol-Myers Squibb, Dey, GlaxoSmithKline, and Pharmacia.

21 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

Roche announced today the submission of a supplemental new biologics license application (sBLA) with the U.S. Food and Drug Administration to market Pegasys(R) (peginterferon alfa-2a) for the treatment of chronic hepatitis B (CHB).

21 Jul 2004

Neuro3d identifies candidate compound

The identification of this compound and extension of the research collaboration by J&JPRD further highlights the strength of Neuro3d's internal drug discovery capabilities.

21 Jul 2004

Debate over acetaminophen and acute liver failure

One expert questions the acceptability of the current level of acetaminophen-related injury and death, while another suggests that acetaminophen overdoses are misunderstood.

20 Jul 2004

FDA is proposing to change the new and generic drug review process

The Food and Drug Administration (FDA) is proposing to change the new and generic drug review processes by replacing "approvable letters" and "not approvable letters" with "complete response letters" that provide companies with specific information about what needs to be done before their drugs can be approved for marketing.

20 Jul 2004

Melanotan-1 can induce tanning in human volunteers who are known to tan easily in response to sunlight

An article in the July issue of the Archives of Dermatology reports that Melanotan-1, a synthetic agent similar to the body's hormone that regulates skin pigmentation, can be combined with UV-B light or sunlight, and appears to act synergistically in the tanning response to light.

20 Jul 2004

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

An article in the July issue of the Archives of Neurology reports that the drugs levodopa and pramipexole both appear to be reasonable options as initial therapy for Parkinson disease, but they are associated with different efficacy and adverse effects.

20 Jul 2004

ARICEPT® delays the onset of Alzheimer's among people with mild cognitive impairment

ARICEPT® a popular Alzheimer's drug has been shown to delay the onset of the disease among people with mild cognitive impairment.

19 Jul 2004

Pharmaceutical News

Pharmaceutical Benefits Scheme (PBS) medicines available faster

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Janssen Pharmaceutica has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®

The Internet has become the street corner for many drug users and traffickers

GlaxoSmithKline to stand trial on AIDS drugs

Plan B has been shown to reduce the risk of pregnancy by 89 percent

New cream treatment for common form of skin cancer

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Lower drug prices could eliminate coverage gap in Medicare Prescription Drug Plan

Court ruling favors State over pharmaceutical manufacturers

A new vaccine that may delay cancer recurrence

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

Neuro3d identifies candidate compound

Debate over acetaminophen and acute liver failure

FDA is proposing to change the new and generic drug review process

Melanotan-1 can induce tanning in human volunteers who are known to tan easily in response to sunlight

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

ARICEPT® delays the onset of Alzheimer's among people with mild cognitive impairment

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News